Kaja Bator

Kaja Bator

Auto-generated profile, based on publicly available information

Kaja Bator

Faculty of Medicine, Wroclaw Medical University, Poland / Wydział Lekarski, Uniwersytet Medyczny we Wrocławiu, Polska

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Pediatria i Medycyna Rodzinna
Verified
Journal Article
Open access
KBKaja Bator
Kaja Bator
WMWeronika Natalia Machaj
Weronika Natalia Machaj
IMIwona Matus
Iwona Matus
KSKrystian Szypuła
Krystian Szypuła
MMMarta Misiuk-Hojło
Marta Misiuk-Hojło

31 March 2024 in Polish Journal of Sports Medicine
Verified
Journal Article
Closed access
KSKrystian Szypuła
Krystian Szypuła
WMWeronika Natalia Machaj
Weronika Natalia Machaj
KBKaja Bator
Kaja Bator
IMIwona Matus
Iwona Matus

31 March 2024 in Polish Journal of Sports Medicine
Verified
Journal Article
Closed access
KSKrystian Szypuła
Krystian Szypuła
WMWeronika Natalia Machaj
Weronika Natalia Machaj
KBKaja Bator
Kaja Bator
IMIwona Matus
Iwona Matus

16 February 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
IMIwona Matus
Iwona Matus
KBKaja Bator
Kaja Bator
WMWeronika Natalia Machaj
Weronika Natalia Machaj
AKAleksandra Krzemienowska-Cebulla
Aleksandra Krzemienowska-Cebulla
MDMateusz Dorochowicz
Mateusz Dorochowicz
MRMaciej Rabczyński
Maciej Rabczyński
Vascular malformations are congenital vascular anomalies resulting from a disruption in the vasculogenesis process. (1) They are congenital changes that enlarge as the child develops and do not undergo spontaneous involution. They can be classified based on the type of vessels involved (capillary, arterial, venous, lymphatic, mixed) and the nature of the vascular flow (low-flow and high-flow). The clinical presentation of vascular malformations is highly diverse, and despite being congenital, they can remain asymptomatic for a long time, complicating the diagnostic process. (1,3) The presence of malformations carries the risk of health-threatening complications. One such complication is Kasabach-Merritt syndrome, characterized by thrombocytopenia, microangiopathic hemolytic anemia, and consumptive coagulopathy in the presence of a rapidly enlarging vascular tumor. (4,5) Another threat is a coagulopathy limited to the vascular anomaly (LIC). It is characterized by elevated D-dimers and fibrin degradation products, low levels of fibrinogen, FV, FVIII, FXIII, and antithrombin, and sometimes mild to moderate thrombocytopenia. (6,7) Early implementation of anticoagulant therapy allows for the avoidance of health-threatening conditions and the development of disseminated intravascular coagulation syndrome (DIC). (8)